Adeia vs Cellebrite DI
Adeia and Cellebrite DI are similar in size: $443m and $476m of revenue in their latest fiscal years. Cellebrite DI grew faster (18.6% against 17.9%). Adeia kept more of each dollar of sales as profit: a net margin of 25.1% against 16.5%. Cellebrite DI carries less debt relative to equity (0.0% against 88.8%).
| Latest fiscal year | AdeiaADEA, 2025 | Cellebrite DICLBT, 2025 |
|---|---|---|
| Revenue | $443m | $476m |
| Revenue growth | 17.9% | 18.6% |
| Net income | $111m | $78.3m |
| Operating margin | 39.5% | 14.0% |
| Net margin | 25.1% | 16.5% |
| Return on equity | 25.3% | 19.1% |
| Free cash flow | $156m | $160m |
| Cash | $73.1m | $124m |
| Total debt | $427m | $0 |
| Debt to equity | 88.8% | 0.0% |
| Dividend per share | $0.20 | — |
| Dividend yield | 1.0% | — |
| Share buybacks | $21.3m | — |
| Employees | 150 | — |
| Market value | $2.04bn | $3.03bn |
| Price vs our value range | Below our value range | Below our value range |
| Moat score | 38 (Weak) | — |
| Insider trades, 12 months | 0 buys, 1 sales | 0 buys, 15 sales |